by Anand Patadiya | Sep 17, 2024
Genevieve M. Boland, MD, PhD, FACS is an Associate Professor of Surgery at Harvard Medical School, Section Head of Melanoma/Sarcoma Surgery, and Surgical Director of the Termeer Center for Targeted Therapies at the Massachusetts General Hospital. Her primary clinical...
by Anand Patadiya | Sep 17, 2024
Dr. Gulley is an internationally recognized expert in cancer immunotherapy with a strong interest in prostate cancer. Since 1998 he has authored and run a variety of clinical trials at the National Cancer Institute. These innovative, investigator-initiated studies...
by Anand Patadiya | Sep 17, 2024
John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the...
by Anand Patadiya | Sep 18, 2024
Dr. Mulé is the Associate Center Director for Translational Science, Interim Associate Center Director for Basic Science, the Michael McGillicuddy Endowed Chair for Melanoma Research and Treatment, and Scientific Director of Cell Based Therapies at the Moffitt Cancer...
by Anand Patadiya | Sep 18, 2024
As Chief of the Laboratory of Tumor Immunology and Biology, Dr. Schlom directs a translational research program in cancer immunology and immunotherapy. He has pioneered the use of novel immunotherapeutics, both as monotherapy and in combination therapies, for a range...
